Reinforcing and sealing structures for bioprinted tissue models, and methods of assembling reinforcing and sealing structures
By designing reinforced and sealing structures for tissue models used in bioprinting, the problem of insufficient organ sealing and tightness in existing technologies has been solved, enabling organ protection and successful transplantation during the bioprinting process.
Patent Information
- Application Number
- CN202380028446.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-18
- Filing Date
- 2023-03-18
- Publication Date
- 2024-11-19
AI Technical Summary
The lack of existing technologies for protecting and sealing bioprinted organs makes it impossible to ensure the integrity and tightness of the organs during printing, bioreactor culture, and transplantation.
A reinforced and sealed structure for bioprinted tissue models has been designed, comprising a shell and a sealing bio-ink. The shell consists of an inner module and an outer module, using biocompatible materials. Specific assembly steps and sealing bio-ink are used to fill the space to ensure the organ's seal and strength.
It enables the maintenance of organ sterility and appropriate vascular deposition during printing, bioreactor culture, and patient implantation, ensuring organ compactness and strength after transplantation, and providing mechanical support and biocompatibility.
Smart Images

Figure CN118984867A_ABST
Abstract
Description
Technical Field
[0001] The object of the present invention is a reinforcing and sealing structure for bioprinted tissue models, and a method of assembling the structure. Background Art
[0002] Document WO1993002635A1 discloses a chamber made of biocompatible material for implantation in the body, containing a material that is immunocompatible with the body, the chamber comprising a valve to ensure the life of the contained biological material. The document does not describe the application of sealed bio-ink.
[0003] Document US5786216A describes a biocompatible capsule for containing cells for implantation, comprising an internal support that provides tensile strength to the capsule. The document does not include information on the possibility of using bio-inks.
[0004] Document US20070276507A1 discloses a method for reconstructing or replacing a laminar tissue organ or tissue structure, such as a bladder of a patient in need of such treatment, comprising the following steps: providing a biocompatible synthetic or natural polymer matrix configured to conform to at least a portion of a luminal organ or tissue structure in need of the treatment; depositing a first cell population on or in a first surface of the polymer matrix; placing a second cell population in a second surface of the polymer matrix and implanting the shaped polymer construct into the patient's body.
[0005] Document US11051509B2 discloses a device that supports the production and regeneration of tissues and organs, which works by itself or in the human body. It describes printing living tissue in a chamber with the flow of fluids, cells and growth factors, the chamber including at least one inflow and outflow port, which enables the circulation of fluids and other biological materials. The chamber is made of biodegradable polymers, glass, plastic and / or metal, and can be configured to accommodate any shape of tissue.
[0006] Document CN111655835A describes a hydrogel comprising gelatin methacrylate, hyaluronic acid methacrylate, and optionally gelatin, collagen, fibrin / thrombin, matrigel, agarose, hyaluronic acid antiramin, gelatin tyramine and alginate. On the other hand, the document does not include information on the use of a reinforced shell for the printed organ.
[0007] Document EP3146939B1 discloses an implantation tool comprising cells / scaffolds and surrounding devices. The scaffold may be a natural hydrogel comprising collagen, hyaluronic acid, alginate, agarose, chitosan, fibrin, gelatin or a copolymer thereof. The device may be used to repair cartilage.
[0008] The prior art describes many examples of applications of implantable devices, including cells, tissues or drugs. The chambers may have perforated or semi-permeable walls. However, in the prior art, there is no information on the application of sets for protecting / ensuring the integrity of ex vivo bioprinted organs, which would include a housing and a bio-ink allowing the housing to be sealed. Summary of the invention
[0009] The aim of the invention is to develop a reinforcement and sealing structure for bioprinted organs, the main element of which is a shell with a special sealing bio-ink. It ensures the proper conditions during the steps of printing, cultivation in a bioreactor, and implantation of the organ in a patient. It allows maintaining sterility, proper deposition of blood vessels, and ensures the tightness and strength of the organ after transplantation into a living body.
[0010] The subject of the present invention is a reinforcement and sealing structure for a tissue model for bioprinting, which includes a shell and a sealed bio-ink, wherein the shell includes an internal module and an external module, wherein the internal module includes a shell base and a perforated cover, and the external module includes a container, which includes a technical valve, an external cover and a plug for the technical valve.
[0011] Preferably, the housing base has markings for calibrating the printer head.
[0012] Preferably, the housing is made of a biocompatible material, preferably a biocompatible resin and / or a biocompatible polymer.
[0013] Preferably, the volume of the housing is adjusted to the volume of the bioprinted tissue model.
[0014] Preferably, a space having a width of not less than 1.0 mm is provided between the bioprinted tissue model and the internal module, and a space having a width of not less than 0.5 mm is provided between the internal module and the external module.
[0015] Preferably, the bio-ink comprises a buffered solution of an extracellular matrix in its composition.
[0016] Preferably, a buffer solution is used as the sealing bio-ink, wherein the buffer solution comprises an extracellular matrix, methacrylated hyaluronic acid, methacrylated gelatin and a photoinitiator, wherein the photoinitiator is preferably lithium phenyl-2,4,6-trimethylbenzoylphosphonate.
[0017] Preferably, a buffer solution is used as the sealing bio-ink, wherein the buffer solution comprises a portion of an extracellular matrix with a concentration ranging from 1 to 10 w / v%, and a mixture of a portion of methacrylated hyaluronic acid with a concentration ranging from 1 to 3 w / v% and a portion of methacrylated gelatin with a concentration ranging from 5 to 25 w / v%, and the addition of a LAP photoinitiator in an amount not exceeding a final concentration of 0.5 w / v%, wherein the ratio of methacrylated hyaluronic acid to methacrylated gelatin in the mixture is 1:0.67.
[0018] The invention also relates to a method for strengthening and sealing a structure, comprising the following steps:
[0019] a) filling the space between the bioprinted tissue model and the housing base with sealing bio-ink;
[0020] b) covering the housing base with the bioprinted tissue model with a perforated cover and pressing to form an inner module;
[0021] c) optionally, refilling the space between the bioprinted tissue model and the housing base with a sealing bio-ink;
[0022] d) sliding the folded inner module into the container to form an outer module;
[0023] e) closing the outer module with an outer cover;
[0024] f) optionally, adding sealed bio-ink via a technical valve;
[0025] g) Install the plug in the technical valve. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] The object of the present invention is presented in the accompanying drawings, in which:
[0027] Figure 1 shows a perspective view of a reinforced housing according to the present invention;
[0028] Figure 2 The disassembled elements of the housing are shown;
[0029] Figure 3 shows a top and side view of the assembled housing;
[0030] Figure 4A table summarizing the stability tests and the evaluation of the usefulness of the selected formulations for sealing bioinks is shown. The following formulations have been tested: a: 10% dECM hydrogel + GelMa + HaMa, b: 10% dECM hydrogel (+GelMa + HaMa) + 1.5% agarose 1:1, c: dECM 5% + 1.5% agarose (1:1), d: 5% dECM hydrogel (+GelMa + HaMa) + 1.5% agarose 2:1, e: 5% dECM hydrogel (+GelMa + HaMa) + 3% agarose 2:1, f: 1% chitosan-based hydrogel + 2% agarose, g: dECM 5% + GelMa + HaMa. DETAILED DESCRIPTION
[0031] The advantage of the present invention is that the whole of the present invention consists of a number of designed and manufactured elements. They ensure the correct performance of the bioprinting process of the tissue model. Among these elements, it can be listed: the outer shell of the bioprinted model and the sealing bio-ink. The outer shell of the model is in turn composed of two modules: an inner module and an outer module.
[0032] Figure 1 A perspective view of the housing is shown. The housing is assembled from components in successive steps of the bioprinting process so that a functional tissue model can be produced in the end. The housing base 1 of the inner module is placed in the bioprinter and filled with bio-ink in a specific and planned way, with or without bio-material.
[0033] This structure of the housing ensures many functions of the structure used. The internal module of the housing has a support and isolation function, and the housing base 1 is able to transport the printed tissue model. In addition, the housing base 1 can have a mark 7, to which the printer head is calibrated, thus playing a calibration function. The housing has a valve for depositing blood vessels, which ensures its correct position and orientation relative to the printed tissue model. In addition to this, the housing base 1 of the housing has a valve that provides support and allows the blood vessels to be fixed relative to the tissue model, providing a support function for the blood vessels. In addition, the internal module is designed and manufactured to ensure the ability to introduce sealing bio-ink between the printed tissue model and the housing. A space is left between the side walls of the housing base 1 and the printed tissue model. The perforated cover 2 allows the introduction of sealing bio-ink to surround the entire tissue model, reaching every free space.
[0034] The external module in turn has functions related to ensuring mechanical strength and ensuring tightness of the entire tissue model; it has a supporting function, since the housing provides the possibility of installing the tissue model in the bioreactor chamber. Furthermore, the shape and position of the appropriately chosen inlet and outlet vessels provide the possibility of implanting the tissue model in a recipient. The external module consists of a container 3 comprising at least two technical valves 5, an outer cover 4 and a stopper 6.
[0035] Figure 2 The elements of the housing after disassembly are shown. The method of assembling the housing and sealing it by sealing ink involves filling the space between the bioprinted organ and the housing base 1 with sealing bio-ink. Subsequently, the housing base 1 with the bioprinted tissue model is covered with a perforated cover 2 and pressed to form an internal module. The perforated cover 2 can optionally be used to replenish the sealing bio-ink. Subsequently, the internal module is slid into the container 3 to produce the external module. The external module is closed with the outer cover 4. The resulting structure is arranged in a vertical position with the outlet of the container facing upwards. Subsequently, the sealing bio-ink is injected through the lower process valve 5. The sealing bio-ink is injected until the sealing bio-ink is observed in the upper technical valve 5. It is necessary to check the correctness of the filling; i.e. visually assess the presence of bubbles. If necessary, the housing is tilted with one of the technical valves 5 upwards and the sealing bio-ink is resupplied. Finally, the stopper 6 is installed in the technical valve and pressed so that the edge of the stopper 6 rests against the wall of the housing.
[0036] The function of ensuring tightness is one of the more important parameters and is the result of the sum of the applied solutions: shell closure method, method of supporting and depositing blood vessels, type of sealing bioink and method of application.
[0037] The housing is made of biocompatible materials. All its components are made of biocompatible silicone, biocompatible resin or biocompatible polymer. In addition to meeting the biocompatibility conditions and having appropriate mechanical properties, the material must also ensure the possibility of sterilization under high temperature and / or radiation sterilization.
[0038] Biocompatible materials are characterized by having an appropriate function in the living body. Materials with high biocompatibility should have the following characteristics: non-toxic; no effect on the body's immune system; no hemolysis.
[0039] The shell can be prepared in various sizes; it is most important to retain its individual components and formulations. The size of the shell must be designed to provide the possibility of bioprinting tissue models within the required volume and thus the possibility of applying sealed bio-inks.
[0040] The sealing bio-ink in turn has functions related to providing appropriate biological conditions for the printed tissue model; it fills the space between the shell element and the tissue model, ensures the adhesion of the main tissue model and the shell element to the bio-ink, and improves the mechanical properties of the bioprinted tissue model.
[0041] One of the components of the sealing bioink is an extracellular matrix produced according to patent application WO2021014359A1. Changes introduced to the procedure, such as the antibiotics used or small conveniences, for example during the pouring process, have no real impact on the overall execution.
[0042] The methacrylated component (such as methacrylated gelatin or methacrylated hyaluronic acid) is a carrier; glycerol is a lubricant; LAP (lithium phenyl-2,4,6-trimethylbenzoylphosphonate) is a photoinitiator.
[0043] A variety of sealing bioinks were tested in the studies conducted:
[0044] -1.5% agarose solution;
[0045] -Chitosan-based hydrogels with added β-glycerophosphate (β-GP);
[0046] -5% dECM hydrogel + GelMa + HaMa;
[0047] -10% dECM hydrogel+GelMa+HaMa;
[0048] -15% dECM hydrogel+GelMa+HaMa;
[0049] -5% dECM hydrogel + dECM powder + GelMa + HaMa;
[0050] -10% dECM hydrogel + dECM powder + GelMa + HaMa;
[0051] -20% GelMa
[0052] -10% GelMa
[0053] -dECM hydrogel (+GelMa+HaMa)+agarose:
[0054] -10% dECM hydrogel (+GelMa+HaMa) + 1.5% agarose (1:1);
[0055] -5% dECM hydrogel (+GelMa+HaMa) + 1.5% agarose (1:1);
[0056] -5% dECM hydrogel (+GelMa+HaMa) + 1.5% agarose (2:1);
[0057] -5% dECM hydrogel (+GelMa+HaMa) + 3% agarose (2:1);
[0058] -Chitosan-based hydrogel + 1.5% agarose (1:1);
[0059] -Chitosan-based hydrogel with addition of β-glycerophosphate (β-GP) + 1.5% agarose (1:1);
[0060] - 1.5% agarose + cellulose (1:1 and 4:1).
[0061] The present invention is presented in the form of non-limiting examples:
[0062] Example 1: Shell production technology
[0063] Strength tests involving pressure limit measurements of bioprinted tissue models form the basis for the necessity of using sealing bioink and each element of the model. The pressure limit conditions that the model must meet depend on the physiological stresses specific to the species and the model being studied. To demonstrate the effectiveness of using sealing bioink, pressure tests were performed. These tests were performed on models without sealing bioink as well as models using it.
[0064] After printing was completed, the model was prepared for pressure supply strength testing. First, the vascular system of the tissue model was unblocked by removing the supporting bio-ink. Subsequently, specially designed connectors were installed on the pancreas, which should have been able to connect drainage tubes to control the flow of culture medium. The test was conducted on two types of models with and without sealing bio-ink.
[0065] To ensure a continuous flow of fluid (optimal rate is 50 to 100 ml / min), the strength test starts with stabilizing the flow of the pancreas to eliminate any air bubbles and residual bio-ink content throughout the system. Subsequently, the system begins to be pressurized. The test is performed until visible leaks appear in the model.
[0066] At pressure values of 15 to 29 mmHg, the model without sealing bioink showed leakage for the first time near the channel entrance. On the other hand, the model sealed with the developed bioink showed leakage for the first time at values of 32 to 49 mmHg. The tests involved a total of 8 full-scale models. Therefore, this shows that the application of sealing bioink is fully justified.
[0067] This is a test of the performance of the sealed bio-ink - it does not use a full reinforced shell. Using the bio-ink and shell, pressures up to 400mmHg can be maintained.
[0068] Filling the gaps between the biomimetic tissue model and the reinforcement shell with dECM-based hydrogels produced a satisfactory sealed bio-coating composition, while also showing complete adhesion to the bio-ink used to print the tissue model. This bio-ink filled all the gaps between the biomimetic organ and the reinforcement layer, providing protection against delamination, thereby preventing leakage of the biomimetic tissue model.
[0069] Example 2: Composition of Sealing Bio-Ink
[0070] Several bioink varieties with different compositions have been tested. Figure 4 Sample results of tests conducted on sealing bioinks with various compositions are shown. Decellularized material was obtained from a local slaughterhouse and directly after preparation, pancreatic tissue was precisely cleaned to remove fat, large blood vessels, and connective tissue and stored in PBS solution before further processing. The entire process was carried out according to the protocol published by Klak M, Int J Mol Sci 2021;22:1-16; https: / / doi.org / 10.3390 / ijms22137005.
[0071] Table 1 Tested types of sealing bio-inks
[0072]
[0073]
[0074] From the tests performed, the sealing bioink with the most preferred characteristics was selected: 5% dECM hydrogel + GelMa + HaMa.
[0075] The characteristics of the selected sealing bio-ink are:
[0076] -High stability in the physiological temperature range,
[0077] - does not exhibit cytotoxicity,
[0078] -Stably adhere to the bio-ink to form the quality of the biomimetic model,
[0079] - Crosslinking occurs due to light with a wavelength of 405nm,
[0080] - exhibits low viscosity,
[0081] - maintain fluidity under experimental conditions, allowing adequate penetration of the model,
[0082] -Exhibits high DS to methacrylates, in order to provide stable fillers,
[0083] -High flexibility of the material after cross-linking, which does not cause delamination.
[0084] Example 3: Cross-linking process:
[0085] Multi-step cross-linking was used, with extended exposure to light at wavelengths of either 405nm or 365nm. First, cross-linking was performed between the biomimetic pancreas and the inner layer of the reinforcing shell, and then the cross-linked bio-ink was introduced between the previously cross-linked reinforcing layer and the outer shell—in this case, the sealing bio-ink was introduced through a technical valve in the outer shell. Cross-linking parameters:
[0086] - Wavelength of 405nm or 365nm;
[0087] - Cross-linking duration is 60s to 2160s (optimal 1440s);
[0088] - For 405nm wavelength, the power is 1 to 30mW / cm 2 (Optimum 28.5mW / cm 2 ), for a wavelength of 365 nm, the power is 1 to 15 mW / cm 2 .
Claims
1. A reinforcement and sealing structure for a tissue model for bioprinting, characterized in that: The reinforcing and sealing structure comprises a shell and a sealing bio-ink, wherein the shell comprises an internal module and an external module, wherein the internal module comprises a shell base (1) and a perforated cover (2), wherein the external module comprises a container (3), wherein the container (3) comprises a technical valve (5), an outer cover (4) and a plug (6) for the technical valve (5).
2. The reinforcement and sealing structure according to claim 1, characterized in that: The housing base (1) has markings (7) for calibrating the print head.
3. The reinforcement and sealing structure according to claim 1 or 2, characterized in that: The shell is made of a biocompatible material, preferably a biocompatible resin and / or a biocompatible polymer.
4. The reinforcement and sealing structure according to any one of claims 1 to 3, characterized in that: The volume of the housing is adjusted to the volume of the bioprinted tissue model.
5. The reinforcement and sealing structure according to any one of claims 1 to 4, characterized in that: A space having a width of not less than 1.0 mm is provided between the bioprinted tissue model and the internal module, and a space having a width of not less than 0.5 mm is provided between the internal module and the external module.
6. The reinforcement and sealing structure according to any one of claims 1 to 5, characterized in that: The bio-ink comprises in its composition a buffered solution of an extracellular matrix.
7. The reinforcement and sealing structure according to any one of claims 1 to 6, characterized in that: A buffer solution is used as the sealing bio-ink, wherein the buffer solution contains an extracellular matrix, methacrylated hyaluronic acid, methacrylated gelatin and a photoinitiator, and the photoinitiator is preferably lithium phenyl-2,4,6-trimethylbenzoylphosphonate.
8. The reinforcement and sealing structure according to any one of claims 1 to 7, characterized in that: A buffer solution is used as a sealing bio-ink, wherein the buffer solution contains a portion of an extracellular matrix with a concentration ranging from 1 to 10 w / v%, and a mixture of a portion of methacrylated hyaluronic acid with a concentration ranging from 1 to 3 w / v% and a portion of methacrylated gelatin with a concentration ranging from 5 to 25 w / v%, and the addition of a LAP photoinitiator in an amount not exceeding a final concentration of 0.5 w / v%, wherein the ratio of methacrylated hyaluronic acid to methacrylated gelatin in the mixture is 1:0.
67.
9. A method for assembling a reinforcement and sealing structure according to any one of claims 1 to 8, characterized in that The method comprises the following steps: h) filling the space between the bioprinted tissue model and the housing base (1) with a sealing bio-ink; i) covering the housing base (1) with the bioprinted tissue model with the perforated cover (2) and pressing to form an internal module; j) optionally, refilling the space between the bioprinted tissue model and the housing base (1) with a sealing bio-ink; k) sliding the folded inner module into the container (3) to form an outer module; 1) closing the external module with an external cover (4); m) optionally, adding sealed bio-ink via a technical valve (5); n) Install the plug (6) in the technical valve (5).
